Triazines

Antiviral Agents
ADS-J1 Inhibits HIV-1 Entry by Interacting with gp120 and Does Not Block Fusion-Active gp41 Core Formation
Emmanuel González-Ortega, Maria-Pau Mena, Marc Permanyer, Ester Ballana, Bonaventura Clotet, José A. Esté
Pharmacology
Antiviral Properties, Metabolism, and Pharmacokinetics of a Novel Azolo-1,2,4-Triazine-Derived Inhibitor of Influenza A and B Virus Replication
Inna Karpenko, Sergey Deev, Oleg Kiselev, Valerey Charushin, Vladimir Rusinov, Eugeney Ulomsky, Ella Deeva, Dmitry Yanvarev, Alexander Ivanov, Olga Smirnova, Sergey Kochetkov, Oleg Chupakhin, Marina Kukhanova
Antiviral Agents
ADS-J1 Inhibits Human Immunodeficiency Virus Type 1 Entry by Interacting with the gp41 Pocket Region and Blocking Fusion-Active gp41 Core Formation
Hongtao Wang, Zhi Qi, Angi Guo, Qinchao Mao, Hong Lu, Xiuli An, Chenglai Xia, Xiaojuan Li, Asim K. Debnath, Shuguang Wu, Shuwen Liu, Shibo Jiang
Experimental Therapeutics
Triazine Inhibits Toxoplasma gondii Tachyzoites In Vitro and In Vivo
Ernest J. Mui, David Jacobus, Wilbur K. Milhous, Guy Schiehser, Honghue Hsu, Craig W. Roberts, Michael J. Kirisits, Rima McLeod
Antiviral Agents
A Series of Diaryltriazines and Diarylpyrimidines Are Highly Potent Nonnucleoside Reverse Transcriptase Inhibitors with Possible Applications as Microbicides
Yven Van Herrewege, Guido Vanham, Jo Michiels, Katrien Fransen, Luc Kestens, Koen Andries, Paul Janssen, Paul Lewi
Experimental Therapeutics
Trypanocidal Activity of Melamine-Based Nitroheterocycles
Mhairi L. Stewart, Gorka Jimenez Bueno, Alessandro Baliani, Burkhard Klenke, Reto Brun, Janice M. Brock, Ian H. Gilbert, Michael P. Barrett
Mechanisms of Action: Physiological Effects
Novel Saccharomyces cerevisiae Screen Identifies WR99210 Analogues That Inhibit Mycobacterium tuberculosis Dihydrofolate Reductase
A'Lissa B. Gerum, Jonathan E. Ulmer, David P. Jacobus, Norman P. Jensen, David R. Sherman, Carol Hopkins Sibley
Antiviral Agents
RFI-641, a Potent Respiratory Syncytial Virus Inhibitor
Clayton C. Huntley, William J. Weiss, Anna Gazumyan, Aron Buklan, Boris Feld, William Hu, Thomas R. Jones, Timothy Murphy, Antonia A. Nikitenko, Bryan O'Hara, Gregory Prince, Susan Quartuccio, Yuri E. Raifeld, Philip Wyde, John F. O'Connell
Experimental Therapeutics
In Vitro and In Vivo Activities of Trybizine Hydrochloride against Various Pathogenic Trypanosome Species
Ronald Kaminsky, Reto Brun
Experimental Therapeutics
Antitrypanosomal Activity of a New Triazine Derivative, SIPI 1029, In Vitro and in Model Infections
Cyrus J. Bacchi, Marcus Vargas, Donna Rattendi, Burt Goldberg, Weicheng Zhou

Main menu

User menu

Search

Triazines

Pages